<DOC>
	<DOCNO>NCT02461797</DOCNO>
	<brief_summary>Recently , critical role development allergic rhinitis ( AR ) attribute nasal epithelium . The airway epithelium form physical barrier , protect nasal mucosa underlie organ damage contact exogenous particle . The nasal epithelial barrier primarily determine integrity airway epithelium , epithelial cell connect complex network structure like tight junction ( TJs ) , ultimately seal paracellular space . TJs consist different transmembrane protein include occludin , tricellulin , claudin family , junctional adhesion molecule . TJ form intercellular homodimers/heterodimers neighbor cell . Scaffold adaptor protein like cingulin zonula occludens family connect transmembrane proteins actin cytoskeleton . Disturbed TJ function facilitate entrance foreign pathogen antigens submucosal layer , give raise allergic sensitization via increased access allergens dendritic cell and/or induce persistent inflammation via activation mast cell inflammatory cell reside upper airway . Chronic disorder like allergic asthma , inflammatory bowel disease atopic dermatitis link defective altered TJ function . Recently , impaired epithelial barrier function find patient chronic rhinosinusitis nasal polyp ( CRSwNP ) , suggest change TJ arrangement nasal cavity . CRSwNP present similar inflammation sinonasal cavity find AR patient , i.e . Th2 cytokine drive inflammation tissue eosinophilia . Nevertheless , role TJs regulation investigate AR .</brief_summary>
	<brief_title>Evaluation Nasal Mucosal Permeability Controls House Dust Mite Allergic Rhinitis Patients</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>1 . Patients ARIAbased diagnosis persistent moderate/severe AR ( â‰¥ 2 nasal symptom suggestive allergic rhinitis positive skin prick test HDM ( HAL Allergy , Leiden , The Netherlands ) , VAS score total nasal symptom 5 2 . Age &gt; 18 &lt; 60 year . 3 . Possibility give reliable information write informed consent 4 . For AR group nasal corticosteroid spray : Patients use nasal corticosteroid spray least three week prior study , minimum application two puff per nostril day . 1 . No common cold last 4 week 2 . Patients prolonged use decongestive nose spray , suffer socalled rhinitis medicamentosa 3 . A . For healthy control AR without use nasal spray : Patients use nasal oral medication affect nasal function , like nasal corticosteroid , anticholinergic , cromoglycates , leukotriene antagonist , ACE inhibitors less 4 week start study . B . For AR group use nasal corticosteroid spray : Patients use nasal oral medication affect nasal function , like anticholinergic , cromoglycates , leukotriene antagonist , ACE inhibitors less 4 week start study . 4 . Nasal endoscopic evidence rhinosinusitis w/wo NP structural abnormality clinically relevant septal deviation ( septum reach concha inferior lateral nasal wall ) septal perforation 5 . Patients immunotherapy ( IT ) house dust mite ( HDM ) history IT HDM 6 . Patient psychiatric , addictive , disorder investigator feel may compromise ability give truly informed consent participation study provide reliable information questionnaire 7 . Patients enrol clinical trial 8 . Pregnancy breastfeed 9 . Malignancies severe comorbidity 10 . Contraindication local anesthesia cocaine 5 % 11 . Smoking 12 . Use anticoagulation medication Healthy control meet exclusion criterion , additional inclusion criterion : 1 . Absence nasal symptoms 2 . Negative history respiratory allergy 3 . Negative skin prick test ( SPT ) result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>